Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03164616 |
|---|---|
| Brief Title: | Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). (POSEIDON) |
| First Submitted : | May 22, 2017 |
| First Submitted that Met QC Criteria : | May 22, 2017 |
| First Posted : | May 23, 2017 |
| Results First Submitted : | March 11, 2022 |
| Results First Submitted that Met QC Criteria : | March 11, 2022 |
| Results First Posted : | April 7, 2022 |
| Last Update Submitted that Met QC Criteria : | March 1, 2024 |
| Last Update Posted : | March 5, 2024 |